SCHEMBL11282178

SCHEMBL11282178

CC(=O)n1nc(C)nc1-c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 6/20 0.73
NR1H3 Q13133 6/20 0.73
TSHR P16473 4/20 0.47
CYP1A2 P05177 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 3/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PIN1 Q13526 1/20 0.40
ELANE P08246 1/20 0.40
USP2 O75604 1/20 0.40
F2 P00734 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10476799 0.84 NR1H2 (1.00) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL17570200 0.83 NR1H2 (0.97) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL17279678 0.80 NR1H2 (0.85) NR1H2NR1H3TSHRCYP1A2HSD17B10
SCHEMBL10476808 0.79 NR1H2 (1.00) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL17570201 0.77 NR1H2 (0.85) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL11272510 0.74 NR1H2 (0.76) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL17279824 0.74 NR1H2 (0.76) NR1H2NR1H3TSHRCYP1A2SMN1; SMN2
SCHEMBL679761 0.71 NR1H3 (0.68) NR1H2NR1H3TSHRHSD17B10LMNA
SCHEMBL15157116 0.70 TSHR (0.49) NR1H2NR1H3TSHRCYP1A2HSD17B10
SCHEMBL1386265 0.69 NR1H2 (0.51) NR1H2NR1H3TSHRSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4332812-A ANTIARTHRITIC E. R. SQUIBB & SONS, INC. (US) 1982-06-01 US disclosed
EP-0003895-A1 1-Acyl-3(5)-alkyl-5(3)-phenyl-1,2,4-triazoles, process for their preparation and pharmaceutical compositions containing them E.R. Squibb & Sons, Inc. (US) 1979-09-05 EP disclosed
US-4154843-A Method of treating psychotic states with 1-acyl-3(5)-alkyl-5(3)-phenyl-1,2,4-triazoles E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed
US-4154841-A Antiinflammatory 1-acyl-3(5)-alkyl-5(3)-phenyl-1,2,4-triazoles E. R. SQUIBB & SONS, INC. (US) 1979-05-15 US disclosed